Immunic stock gains 6% on FDA go ahead for IMU-838 trials in multiple sclerosis

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Immunic stock gains 6% on FDA go ahead for IMU-838 trials in multiple sclerosis

To read the full story on Seeking Alpha, click here.

Immunic (NASDAQ:IMUX)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Immunic Charts.

Immunic (NASDAQ:IMUX)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Immunic Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Immunic Inc News

More Immunic Inc News Articles

Lehman Brothers Financial (CE)

Moon Equity (PK)

Valiant Eagle (PK)

TheGlobe com (PK)

BlackStar Enterprise (PK)

Kraig Biocraft Laborator... (QB)

Baron Capital Enterprise (CE)

Code Green Apparel (PK)

Global Developments (PK)

Enzolytics (PK)

Tonner One World (PK)

Branded Legacy (PK)

Delayed Upgrade Clock